Skip to main content

Table 3 Tukey-honest significant differences post-hoc test for Bio-Plex data [Stage specific (A-D)] and healthy unaffected control (group E)

From: A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages A-D colorectal cancers

Candidate Biomarker

Comparison

Adjusted p-value

Previous studies referencing CRC association

IL-8

D/E

6.00E-05

[44,47]

 

A/E

6.00E-03

 
 

B/E

2.00E-03

 

PDGF-BB

D/E

2.00E-07

[22,55]

 

D/A

4.00E-03

 

CCL2

D/E

5.00E-04

[61-63]

IFNG

D/E

0.002

[63]

IL-4

D/E

0.004

[64]

CCL3

D/E

0.004

[65]